2013
DOI: 10.1016/j.vetmic.2013.01.018
|View full text |Cite
|
Sign up to set email alerts
|

In vitro antiviral activity of fluoroquinolones against African swine fever virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
30
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 46 publications
(34 citation statements)
references
References 21 publications
2
30
0
Order By: Relevance
“…uncinatus . Similar report has been associated with increasing dose of other drugs tested against the virus [13,33,34]. The antiviral activities of this plant are comparable to those of Lauryl gallate and mulberry twigs which caused significantly reduced viral titres and inhibition of viral DNA replication at non-toxic doses [13,34].…”
Section: Discussionsupporting
confidence: 67%
See 1 more Smart Citation
“…uncinatus . Similar report has been associated with increasing dose of other drugs tested against the virus [13,33,34]. The antiviral activities of this plant are comparable to those of Lauryl gallate and mulberry twigs which caused significantly reduced viral titres and inhibition of viral DNA replication at non-toxic doses [13,34].…”
Section: Discussionsupporting
confidence: 67%
“…The drug also caused altered viral protein possibly because of the putative ASFV-topoisomerase II enzyme which was targeted and had its activity modified [33]. Lauryl gallate has been tested and confirmed to strongly inhibit African swine fever virus at non-toxic concentration.…”
Section: Introductionmentioning
confidence: 99%
“…Although P1192R was identified as having homology to type II topoisomerases (Baylis et al, 1992;García-Beato et al, 1992) and it has been suggested that type II topoisomerase-inhibiting drugs have an effect on ASFV (Mottola et al, 2013;Salas et al, 1983), proof of pP1192R functionality remained unaddressed. Heterologous expression of P1192R using either prokaryotic or eukaryotic systems had been proposed and/or attempted by different research groups but, to our knowledge, the proteins obtained have never been shown to possess type II DNA topoisomerase activity.…”
Section: Discussionmentioning
confidence: 99%
“…Here, we have reviewed potential molecular targets to be considered as targets for antivirals. Antivirals against ASFV described include resveratrol and oxyresveratrol [73], microalgae [74], cholesterol lowering drugs [46] or inhibitors of cholesterol transport [42], antitumoral lauryl-gallate [75], anticonvulsivant valproic acid [75], dynamin inhibitors [38], fluoroquinolones [76], serine protease inhibitors [52], specific peptides [77], and miscelanea [32]. These could be eventually applied in a quick response to reduce susceptible animals in order to create ‘safe areas’ around the outbreaks and thus control the spread of the infection.…”
Section: Potential Vaccines and Antiviralsmentioning
confidence: 99%